It was shown that among individuals with LDL-C ≥ 4.9 mmol/L, those with pathogenic mutations identified by sequencing three main FH genes (LDLR, APOB and PCSK9) have approximately 3.7-fold higher risk for coronary artery disease [21]. This evidence concerns the gene APOB and coronary artery disorder.